Lietman Steven A, Barsoum Wael K, Goldblum J R, Marks Kenneth E, Mascha Edward, Sundaram Murali, Muschler George
The Cleveland Clinic, Cleveland, OH 44195, USA.
Orthopedics. 2007 Mar;30(3):227-34. doi: 10.3928/01477447-20070301-01.
The records of 63 patients surgically treated for liposarcoma at the Cleveland Clinic between 1975 and 1995 were examined. Both metastatic disease (Enneking stage IIl) and an abdominal location were found to be poor prognosticants for survival. Age, gender, or tumor size, setting, or grade did not have any prognostic significance. The 5-year disease-specific survival for extremity tumors was 92% (95% confidence interval [CI]; range: 84%-100%), while general 5-year survival for extremity tumors was 66% (95% Cl; range: 48%-85%).
对1975年至1995年间在克利夫兰诊所接受手术治疗的63例脂肪肉瘤患者的记录进行了检查。发现转移性疾病(Enneking III期)和腹部位置均为生存的不良预后因素。年龄、性别、肿瘤大小、部位或分级均无预后意义。肢体肿瘤的5年疾病特异性生存率为92%(95%置信区间[CI];范围:84%-100%),而肢体肿瘤的总体5年生存率为66%(95%CI;范围:48%-85%)。